Briscoe group managing director Rod Duke is not willing to sacrifice market share in FY26.
Documents filed for new global equities fund.
JBWere senior investment analyst Philip Borkin on the week ahead.
Peter Meintjes has track record for commercialising disruptive biotech, company says.
But acting chief executive Liam Mason concedes it has real concerns about sector.
UPDATE: Shares plunge 10% as market reacts.
Angel at My Table: Early-stage deals were up 60% in the first half of 2021.
Companies stay positive as regulator focuses on local market.
Harbour Asset Management portfolio manager Shane Solly on the week ahead.
Deal takes portfolio to 10,800ha of dairy assets.
